What is the cost of bosulif?
The cost for Bosulif oral tablet 100 mg is around $17,190 for a supply of 120 tablets, depending on the pharmacy you visit….Oral Tablet.
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $573.01 | $17,190.18 |
Is there a generic bosulif?
Generic name: Bosutinib Bosulif® is the trade for the generic chemotherapy drug Bosutinib. In some cases, health care professionals may use the generic name Bosutinib when referring to the trade name Bosulif®. Drug type: Bosulif® is a targeted therapy.
Does bosulif cause hair loss?
Other medications used to treat Ph+ CML are Bosulif, Gleevec and Sprycel which have varying rates of hair loss according to clinical trials.
What are the side effects of bosutinib?
Nausea, vomiting, stomach/abdominal pain, loss of appetite, cough, joint pain, headache, or dizziness may occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly. Diarrhea is a common side effect.
How often do you take BOSULIF?
CP, AP, Or BP Ph+ CML With Resistance Or Intolerance To Prior Therapy. The recommended dose and schedule of BOSULIF is 500 mg orally once daily with food.
How do you take BOSULIF?
Both Bosulif and Sprycel come as a tablet you take by mouth. Bosulif is taken once a day with food. Sprycel is taken once a day, either in the morning or the evening. Sprycel can be taken with or without food.
How do you take bosulif?
Is bosutinib chemotherapy?
Bosutinib is the generic for the trade chemotherapy drug Bosulif®. In some cases, health care professionals may use the trade name Bosulif ® when referring to the generic drug name bosutinib. Drug type: Bosutinib is a targeted therapy.
How do you take bosutinib?
Bosutinib comes as a tablet to take by mouth. It should be taken once a day with food. Take bosutinib at around the same time every day. Do not crush, break or chew bosutinib tablets.
How effective is bosulif?
Effectiveness for newly diagnosed Ph+ CML Bosulif has been found to be effective in treating newly diagnosed Ph+ CML in people who haven’t received treatment for their cancer before. For this use, Bosulif received accelerated approval from the FDA. Accelerated approval is based on early clinical trial data.